The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

Friday initiated legal action against the three largest prescription drug benefit managers (PBMs) in the U.S.—Caremark Rx, ...

The federal government has initiated a lawsuit against leading Pharmacy Benefit Managers (PBMs) — Caremark, Express Scripts, and OptumRx — accusing them of anticompetitive practices that have driven ...

Sources familiar with the investigation say federal authorities have subpoenaed Molly Schaeffer, director of the Office of Asylum Seeker Operations. Sources say the subpoena was seeking her testimony.